Carbapenem-resistant Pseudomonas aeruginosa is one of the major concerns in clinical
settings impelling a great challenge to antimicrobial therapy for patients with infections …

Pseudomonas aeruginosa (P. aeruginosa) is an opportunistic pathogen associated with a
range of nosocomial infections. This microorganism is noted for its intrinsic resistance to …

Background Carbapenemase genes are one of the most frequent mechanisms reported in
carbapenem-resistant P. aeruginosa; however, description of P. aeruginosa co-harbouring …

Carbapenem-resistant Pseudomonas aeruginosa (CR-PA) is a major healthcare-associated
pathogen worldwide. In the United States, 10–30% of P. aeruginosa isolates are …

Carbapenems are important agents for the therapy of infections due to multidrug-resistant
Pseudomonas aeruginosa; the development of carbapenem resistance hampers effective …

Abstract Background Multidrug-resistant Pseudomonas aeruginosa is a serious challenge
for antimicrobial therapy of nosocomial infections, as it possesses several mechanisms of …

Horizontal gene transfer (HGT) is a driving force to the evolution of bacteria. The fast
emergence of antimicrobial resistance reflects the ability of genetic adaptation of pathogens …

We investigated the molecular epidemiology and carbapenem resistance mechanisms of
258 non-duplicate carbapenem-resistant clinical isolates of Pseudomonas aeruginosa …

In this review, we explore some aspects of Pseudomonas aeruginosa virulence factors that
are related to disease development in healthy organisms and resistance to antibiotics. This …

Imipenem resistance in Pseudomonas aeruginosa is considered to be associated with loss
of the porin OprD combined with activity of chromosomal β‐lactamase (AmpC), while …